Stock PMN PROMIS NEUROSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ProMIS Neurosciences, Inc.

Equities

PMN

CA74346M4065

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-30 EDT 		5-day change 1st Jan Change
1.704 USD -2.07% Intraday chart for ProMIS Neurosciences, Inc. +1.46% +48.22%
05-15 ProMIS Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-30 ProMIS Neurosciences, Inc. Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies CI

Evolution of the average Target Price on ProMIS Neurosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

95489ff73c709692481ff877be9ba7.3TkLIA5dWt7TL4nCCm4L4YofjQbrIxVQCEyxZCaYJxQ.6XJ9R1FlGKyJaqSTeQVPpOB8wUqYFXQhOgDySW_1ZVrscTN4aQ4blOFd6g~677c4da73ae605725a8c64dd0fb90bb4

Analyst Recommendations on ProMIS Neurosciences, Inc.

BTIG Starts ProMIS Neurosciences With Buy Rating, Price Target is $8 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.329 CAD
Average target price
13.05 CAD
Spread / Average Target
+460.44%
High Price Target
13.05 CAD
Spread / Highest target
+460.44%
Low Price Target
13.05 CAD
Spread / Lowest Target
+460.44%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ProMIS Neurosciences, Inc.

BTIG

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PMN Stock
  4. Consensus ProMIS Neurosciences, Inc.